{"entity":{"type":"insider","cik":"0001410520","url":"/insider/0001410520","json_url":"/insider/0001410520.json","name":"Bradley Scott","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":213,"n_filings":43,"first":"2007-12-27","last":"2008-06-19","span_basis":"filed_date"},"name_variants":[{"name":"Bradley Scott","source":"filing","n_filings":43,"first_seen":"2007-12-27","last_seen":"2008-06-19"}],"transactions":[{"id":2302459,"accession":"0000909012-08-000731","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000909012-08-000731","line_url":"/filing/0000909012-08-000731","is_derivative":false,"issuer_cik":"0001023549","issuer_name":"XTL BIOPHARMACEUTICALS LTD","issuer_ticker":"XTLB","issuer_name_source":null,"issuer_url":"/issuer/0001023549","owner_cik":null,"owner_name":"Bradley Scott; EDELMAN JOSEPH; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Cho Michael; PERCEPTIVE ADVISORS LLC","owner_display_name":"Bradley Scott","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":51000.0,"shares_display":"51,000","price_per_share":3.23,"price_display":"3.23","price_state":"stated","total_value":164730.0,"total_display":"164,730.00","total_whole":"164,730","shares_owned_after":57558070.0,"shares_owned_after_display":"57,558,070","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-10","filed_date":"2008-06-19","scope":"insider","n_lines":2},{"id":2857223,"accession":"0000909012-08-000713","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000909012-08-000713","line_url":"/filing/0000909012-08-000713","is_derivative":false,"issuer_cik":"0001023549","issuer_name":"XTL BIOPHARMACEUTICALS LTD","issuer_ticker":"XTLB","issuer_name_source":null,"issuer_url":"/issuer/0001023549","owner_cik":null,"owner_name":"PERCEPTIVE ADVISORS LLC; Bradley Scott; Cho Michael; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; EDELMAN JOSEPH","owner_display_name":"PERCEPTIVE ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":33600.0,"shares_display":"33,600","price_per_share":3.36,"price_display":"3.36","price_state":"stated","total_value":112896.0,"total_display":"112,896.00","total_whole":"112,896","shares_owned_after":57509110.0,"shares_owned_after_display":"57,509,110","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-09","filed_date":"2008-06-11","scope":"insider","n_lines":2},{"id":2857207,"accession":"0000909012-08-000713","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000909012-08-000713","line_url":"/filing/0000909012-08-000713","is_derivative":false,"issuer_cik":"0001023549","issuer_name":"XTL BIOPHARMACEUTICALS LTD","issuer_ticker":"XTLB","issuer_name_source":null,"issuer_url":"/issuer/0001023549","owner_cik":null,"owner_name":"PERCEPTIVE ADVISORS LLC; Bradley Scott; Cho Michael; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; EDELMAN JOSEPH","owner_display_name":"PERCEPTIVE ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":3.43,"price_display":"3.43","price_state":"stated","total_value":343000.0,"total_display":"343,000.00","total_whole":"343,000","shares_owned_after":57476850.0,"shares_owned_after_display":"57,476,850","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-06","filed_date":"2008-06-11","scope":"insider","n_lines":2},{"id":2857197,"accession":"0000909012-08-000713","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000909012-08-000713","line_url":"/filing/0000909012-08-000713","is_derivative":false,"issuer_cik":"0001023549","issuer_name":"XTL BIOPHARMACEUTICALS LTD","issuer_ticker":"XTLB","issuer_name_source":null,"issuer_url":"/issuer/0001023549","owner_cik":null,"owner_name":"PERCEPTIVE ADVISORS LLC; Bradley Scott; Cho Michael; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; EDELMAN JOSEPH","owner_display_name":"PERCEPTIVE ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300000.0,"shares_display":"300,000","price_per_share":3.223333333333333,"price_display":"3.22","price_state":"stated","total_value":967000.0,"total_display":"967,000.00","total_whole":"967,000","shares_owned_after":57380850.0,"shares_owned_after_display":"57,380,850","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-05","filed_date":"2008-06-11","scope":"insider","n_lines":4},{"id":3697370,"accession":"0000909012-08-000690","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000909012-08-000690","line_url":"/filing/0000909012-08-000690","is_derivative":false,"issuer_cik":"0001023549","issuer_name":"XTL BIOPHARMACEUTICALS LTD","issuer_ticker":"XTLB","issuer_name_source":null,"issuer_url":"/issuer/0001023549","owner_cik":null,"owner_name":"PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; PERCEPTIVE ADVISORS LLC; EDELMAN JOSEPH; Bradley Scott; Cho Michael","owner_display_name":"PERCEPTIVE LIFE SCIENCES MASTER FUND LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":2.99,"price_display":"2.99","price_state":"stated","total_value":74750.0,"total_display":"74,750.00","total_whole":"74,750","shares_owned_after":57092850.0,"shares_owned_after_display":"57,092,850","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-04","filed_date":"2008-06-06","scope":"insider","n_lines":2},{"id":3697366,"accession":"0000909012-08-000690","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000909012-08-000690","line_url":"/filing/0000909012-08-000690","is_derivative":false,"issuer_cik":"0001023549","issuer_name":"XTL BIOPHARMACEUTICALS LTD","issuer_ticker":"XTLB","issuer_name_source":null,"issuer_url":"/issuer/0001023549","owner_cik":null,"owner_name":"PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; PERCEPTIVE ADVISORS LLC; EDELMAN JOSEPH; Bradley Scott; Cho Michael","owner_display_name":"PERCEPTIVE LIFE SCIENCES MASTER FUND LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400730.0,"shares_display":"400,730","price_per_share":3.03,"price_display":"3.03","price_state":"stated","total_value":1214211.9,"total_display":"1,214,211.90","total_whole":"1,214,212","shares_owned_after":57068850.0,"shares_owned_after_display":"57,068,850","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-03","filed_date":"2008-06-06","scope":"insider","n_lines":2},{"id":3113944,"accession":"0000909012-08-000654","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000909012-08-000654","line_url":"/filing/0000909012-08-000654#line-1","is_derivative":false,"issuer_cik":"0001047188","issuer_name":"PENWEST PHARMACEUTICALS CO","issuer_ticker":"PPCO","issuer_name_source":null,"issuer_url":"/issuer/0001047188","owner_cik":null,"owner_name":"EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; Bradley Scott; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":12500.0,"total_display":"12,500.00","total_whole":"12,500","shares_owned_after":6296046.0,"shares_owned_after_display":"6,296,046","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-05-15","filed_date":"2008-05-20","scope":"insider"},{"id":3898188,"accession":"0000909012-08-000594","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000909012-08-000594","line_url":"/filing/0000909012-08-000594#line-1","is_derivative":false,"issuer_cik":"0001047188","issuer_name":"PENWEST PHARMACEUTICALS CO","issuer_ticker":"PPCO","issuer_name_source":null,"issuer_url":"/issuer/0001047188","owner_cik":null,"owner_name":"EDELMAN JOSEPH; Bradley Scott; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":12500.0,"total_display":"12,500.00","total_whole":"12,500","shares_owned_after":6293546.0,"shares_owned_after_display":"6,293,546","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-05-07","filed_date":"2008-05-12","scope":"insider"},{"id":3921495,"accession":"0000909012-08-000571","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000909012-08-000571","line_url":"/filing/0000909012-08-000571","is_derivative":false,"issuer_cik":"0001023549","issuer_name":"XTL BIOPHARMACEUTICALS LTD","issuer_ticker":"XTLB","issuer_name_source":null,"issuer_url":"/issuer/0001023549","owner_cik":null,"owner_name":"EDELMAN JOSEPH; Bradley Scott; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Cho Michael; PERCEPTIVE ADVISORS LLC","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":3.88,"price_display":"3.88","price_state":"stated","total_value":194000.0,"total_display":"194,000.00","total_whole":"194,000","shares_owned_after":56683890.0,"shares_owned_after_display":"56,683,890","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-05-02","filed_date":"2008-05-06","scope":"insider","n_lines":2},{"id":3921491,"accession":"0000909012-08-000571","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000909012-08-000571","line_url":"/filing/0000909012-08-000571","is_derivative":false,"issuer_cik":"0001023549","issuer_name":"XTL BIOPHARMACEUTICALS LTD","issuer_ticker":"XTLB","issuer_name_source":null,"issuer_url":"/issuer/0001023549","owner_cik":null,"owner_name":"EDELMAN JOSEPH; Bradley Scott; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Cho Michael; PERCEPTIVE ADVISORS LLC","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":105000.0,"shares_display":"105,000","price_per_share":3.75,"price_display":"3.75","price_state":"stated","total_value":393750.0,"total_display":"393,750.00","total_whole":"393,750","shares_owned_after":56635890.0,"shares_owned_after_display":"56,635,890","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-05-01","filed_date":"2008-05-06","scope":"insider","n_lines":2},{"id":2302449,"accession":"0000909012-08-000560","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000909012-08-000560","line_url":"/filing/0000909012-08-000560","is_derivative":false,"issuer_cik":"0001023549","issuer_name":"XTL BIOPHARMACEUTICALS LTD","issuer_ticker":"XTLB","issuer_name_source":null,"issuer_url":"/issuer/0001023549","owner_cik":null,"owner_name":"PERCEPTIVE ADVISORS LLC; Bradley Scott; Cho Michael; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; EDELMAN JOSEPH","owner_display_name":"PERCEPTIVE ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":128370.0,"shares_display":"128,370","price_per_share":3.7437,"price_display":"3.74","price_state":"stated","total_value":480578.769,"total_display":"480,578.77","total_whole":"480,579","shares_owned_after":56535090.0,"shares_owned_after_display":"56,535,090","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-04-30","filed_date":"2008-05-02","scope":"insider","n_lines":2},{"id":2302440,"accession":"0000909012-08-000560","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000909012-08-000560","line_url":"/filing/0000909012-08-000560","is_derivative":false,"issuer_cik":"0001023549","issuer_name":"XTL BIOPHARMACEUTICALS LTD","issuer_ticker":"XTLB","issuer_name_source":null,"issuer_url":"/issuer/0001023549","owner_cik":null,"owner_name":"PERCEPTIVE ADVISORS LLC; Bradley Scott; Cho Michael; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; EDELMAN JOSEPH","owner_display_name":"PERCEPTIVE ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":229240.0,"shares_display":"229,240","price_per_share":3.5379,"price_display":"3.54","price_state":"stated","total_value":811028.196,"total_display":"811,028.20","total_whole":"811,028","shares_owned_after":56441850.0,"shares_owned_after_display":"56,441,850","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-04-29","filed_date":"2008-05-02","scope":"insider","n_lines":2},{"id":3435962,"accession":"0000909012-08-000523","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000909012-08-000523","line_url":"/filing/0000909012-08-000523","is_derivative":false,"issuer_cik":"0001023549","issuer_name":"XTL BIOPHARMACEUTICALS LTD","issuer_ticker":"XTLB","issuer_name_source":null,"issuer_url":"/issuer/0001023549","owner_cik":null,"owner_name":"Bradley Scott; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; PERCEPTIVE ADVISORS LLC; Cho Michael; EDELMAN JOSEPH","owner_display_name":"Bradley Scott","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":3.5759,"price_display":"3.58","price_state":"stated","total_value":357590.0,"total_display":"357,590.00","total_whole":"357,590","shares_owned_after":56191770.0,"shares_owned_after_display":"56,191,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-04-10","filed_date":"2008-04-16","scope":"insider","n_lines":2},{"id":2647656,"accession":"0000909012-08-000497","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000909012-08-000497","line_url":"/filing/0000909012-08-000497","is_derivative":false,"issuer_cik":"0001023549","issuer_name":"XTL BIOPHARMACEUTICALS LTD","issuer_ticker":"XTLB","issuer_name_source":null,"issuer_url":"/issuer/0001023549","owner_cik":null,"owner_name":"Cho Michael; Bradley Scott; PERCEPTIVE ADVISORS LLC; EDELMAN JOSEPH; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD","owner_display_name":"Cho Michael","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":301000.0,"shares_display":"301,000","price_per_share":3.1625,"price_display":"3.16","price_state":"stated","total_value":951912.5,"total_display":"951,912.50","total_whole":"951,913","shares_owned_after":56101770.0,"shares_owned_after_display":"56,101,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-04-01","filed_date":"2008-04-04","scope":"insider","n_lines":4},{"id":2434187,"accession":"0000909012-08-000494","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000909012-08-000494","line_url":"/filing/0000909012-08-000494","is_derivative":false,"issuer_cik":"0001023549","issuer_name":"XTL BIOPHARMACEUTICALS LTD","issuer_ticker":"XTLB","issuer_name_source":null,"issuer_url":"/issuer/0001023549","owner_cik":null,"owner_name":"PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; PERCEPTIVE ADVISORS LLC; Cho Michael; EDELMAN JOSEPH; Bradley Scott","owner_display_name":"PERCEPTIVE LIFE SCIENCES MASTER FUND LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":2.8984,"price_display":"2.90","price_state":"stated","total_value":72460.0,"total_display":"72,460.00","total_whole":"72,460","shares_owned_after":55820820.0,"shares_owned_after_display":"55,820,820","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-28","filed_date":"2008-04-02","scope":"insider","n_lines":2},{"id":2302433,"accession":"0000909012-08-000488","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000909012-08-000488","line_url":"/filing/0000909012-08-000488","is_derivative":false,"issuer_cik":"0001047188","issuer_name":"PENWEST PHARMACEUTICALS CO","issuer_ticker":"PPCO","issuer_name_source":null,"issuer_url":"/issuer/0001047188","owner_cik":null,"owner_name":"EDELMAN JOSEPH; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; PERCEPTIVE ADVISORS LLC; Bradley Scott","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1340300.0,"shares_display":"1,340,300","price_per_share":5.022009997761695,"price_display":"5.02","price_state":"stated","total_value":6731000.0,"total_display":"6,731,000.00","total_whole":"6,731,000","shares_owned_after":6291046.0,"shares_owned_after_display":"6,291,046","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-20","filed_date":"2008-04-01","scope":"insider","n_lines":3},{"id":3976733,"accession":"0000909012-08-000454","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000909012-08-000454","line_url":"/filing/0000909012-08-000454#line-7","is_derivative":false,"issuer_cik":"0001047188","issuer_name":"PENWEST PHARMACEUTICALS CO","issuer_ticker":"PPCO","issuer_name_source":null,"issuer_url":"/issuer/0001047188","owner_cik":null,"owner_name":"Bradley Scott; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; EDELMAN JOSEPH","owner_display_name":"Bradley Scott","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":7.5,"price_display":"7.50","price_state":"stated","total_value":6000.0,"total_display":"6,000.00","total_whole":"6,000","shares_owned_after":5040746.0,"shares_owned_after_display":"5,040,746","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-18","filed_date":"2008-03-20","scope":"insider"},{"id":3921487,"accession":"0000909012-08-000455","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000909012-08-000455","line_url":"/filing/0000909012-08-000455","is_derivative":false,"issuer_cik":"0001023549","issuer_name":"XTL BIOPHARMACEUTICALS LTD","issuer_ticker":"XTLB","issuer_name_source":null,"issuer_url":"/issuer/0001023549","owner_cik":null,"owner_name":"Bradley Scott; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Cho Michael; PERCEPTIVE ADVISORS LLC; EDELMAN JOSEPH","owner_display_name":"Bradley Scott","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":163000.0,"shares_display":"163,000","price_per_share":3.1202,"price_display":"3.12","price_state":"stated","total_value":508592.6,"total_display":"508,592.60","total_whole":"508,593","shares_owned_after":55797070.0,"shares_owned_after_display":"55,797,070","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-18","filed_date":"2008-03-20","scope":"insider","n_lines":2},{"id":3921483,"accession":"0000909012-08-000455","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000909012-08-000455","line_url":"/filing/0000909012-08-000455","is_derivative":false,"issuer_cik":"0001023549","issuer_name":"XTL BIOPHARMACEUTICALS LTD","issuer_ticker":"XTLB","issuer_name_source":null,"issuer_url":"/issuer/0001023549","owner_cik":null,"owner_name":"Bradley Scott; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Cho Michael; PERCEPTIVE ADVISORS LLC; EDELMAN JOSEPH","owner_display_name":"Bradley Scott","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":463000.0,"shares_display":"463,000","price_per_share":3.3269235421166305,"price_display":"3.33","price_state":"stated","total_value":1540365.6,"total_display":"1,540,365.60","total_whole":"1,540,366","shares_owned_after":55452720.0,"shares_owned_after_display":"55,452,720","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-14","filed_date":"2008-03-20","scope":"insider","n_lines":4},{"id":3921477,"accession":"0000909012-08-000455","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000909012-08-000455","line_url":"/filing/0000909012-08-000455","is_derivative":false,"issuer_cik":"0001023549","issuer_name":"XTL BIOPHARMACEUTICALS LTD","issuer_ticker":"XTLB","issuer_name_source":null,"issuer_url":"/issuer/0001023549","owner_cik":null,"owner_name":"Bradley Scott; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Cho Michael; PERCEPTIVE ADVISORS LLC; EDELMAN JOSEPH","owner_display_name":"Bradley Scott","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14820.0,"shares_display":"14,820","price_per_share":3.377465991902834,"price_display":"3.38","price_state":"stated","total_value":50054.046,"total_display":"50,054.05","total_whole":"50,054","shares_owned_after":2943920.0,"shares_owned_after_display":"2,943,920","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-13","filed_date":"2008-03-20","scope":"insider","n_lines":2},{"id":3338115,"accession":"0000909012-08-000447","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000909012-08-000447","line_url":"/filing/0000909012-08-000447","is_derivative":false,"issuer_cik":"0001023549","issuer_name":"XTL BIOPHARMACEUTICALS LTD","issuer_ticker":"XTLB","issuer_name_source":null,"issuer_url":"/issuer/0001023549","owner_cik":null,"owner_name":"Cho Michael; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; Bradley Scott","owner_display_name":"Cho Michael","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":232180.0,"shares_display":"232,180","price_per_share":3.377465991902834,"price_display":"3.38","price_state":"stated","total_value":784180.054,"total_display":"784,180.05","total_whole":"784,180","shares_owned_after":55111500.0,"shares_owned_after_display":"55,111,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-13","filed_date":"2008-03-19","scope":"insider","n_lines":2},{"id":3976732,"accession":"0000909012-08-000454","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000909012-08-000454","line_url":"/filing/0000909012-08-000454#line-6","is_derivative":false,"issuer_cik":"0001047188","issuer_name":"PENWEST PHARMACEUTICALS CO","issuer_ticker":"PPCO","issuer_name_source":null,"issuer_url":"/issuer/0001047188","owner_cik":null,"owner_name":"Bradley Scott; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; EDELMAN JOSEPH","owner_display_name":"Bradley Scott","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7400.0,"shares_display":"7,400","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":37000.0,"total_display":"37,000.00","total_whole":"37,000","shares_owned_after":5039946.0,"shares_owned_after_display":"5,039,946","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-12","filed_date":"2008-03-20","scope":"insider"},{"id":3921472,"accession":"0000909012-08-000455","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000909012-08-000455","line_url":"/filing/0000909012-08-000455","is_derivative":false,"issuer_cik":"0001023549","issuer_name":"XTL BIOPHARMACEUTICALS LTD","issuer_ticker":"XTLB","issuer_name_source":null,"issuer_url":"/issuer/0001023549","owner_cik":null,"owner_name":"Bradley Scott; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Cho Michael; PERCEPTIVE ADVISORS LLC; EDELMAN JOSEPH","owner_display_name":"Bradley Scott","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26400.0,"shares_display":"26,400","price_per_share":3.3555545454545452,"price_display":"3.36","price_state":"stated","total_value":88586.64,"total_display":"88,586.64","total_whole":"88,587","shares_owned_after":2926100.0,"shares_owned_after_display":"2,926,100","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-12","filed_date":"2008-03-20","scope":"insider","n_lines":2},{"id":3338108,"accession":"0000909012-08-000447","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000909012-08-000447","line_url":"/filing/0000909012-08-000447#line-12","is_derivative":false,"issuer_cik":"0001023549","issuer_name":"XTL BIOPHARMACEUTICALS LTD","issuer_ticker":"XTLB","issuer_name_source":null,"issuer_url":"/issuer/0001023549","owner_cik":null,"owner_name":"Cho Michael; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; Bradley Scott","owner_display_name":"Cho Michael","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":272600.0,"shares_display":"272,600","price_per_share":3.3501,"price_display":"3.35","price_state":"stated","total_value":913237.26,"total_display":"913,237.26","total_whole":"913,237","shares_owned_after":54973320.0,"shares_owned_after_display":"54,973,320","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-12","filed_date":"2008-03-19","scope":"insider"}],"collapsed":true,"next_cursor":"2008-03-12|3338108","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001023549","name":"XTL BIOPHARMACEUTICALS LTD","url":"/issuer/0001023549","role":"Ten percent owner","n_filings":32,"first_seen":"2007-12-31","last_seen":"2008-06-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001047188","name":"PENWEST PHARMACEUTICALS CO","url":"/issuer/0001047188","role":"Ten percent owner","n_filings":10,"first_seen":"2008-01-31","last_seen":"2008-05-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001142576","name":"OPTIMER PHARMACEUTICALS INC","url":"/issuer/0001142576","role":"Ten percent owner","n_filings":1,"first_seen":"2007-12-27","last_seen":"2007-12-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001410520","retrieved_at":"2026-08-24T14:17:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}